Results 81 to 90 of about 255,748 (249)

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

open access: yesHaematologica, 2017
A novel therapeutic approach in cancer, attempting to stimulate host anti-tumor immunity, involves blocking of immune checkpoints. Lymphocyte activation gene 3 (LAG3) is an immune checkpoint receptor expressed on activated/exhausted T cells. When engaged
Mika Shapiro   +9 more
doaj   +1 more source

Major Histocompatibility Complex and Cell Cooperation [PDF]

open access: yes, 2017
We have studied the role of major histocompatibility antigens on cell cooperation in the immune response of the chicken. In the 1970's, shortly after the initial discoveries in the mouse, we demonstrated that the T cell-B cell interaction is major ...
TOIVANEN, AULI   +2 more
core  

Trypanosoma brucei brucei infection impairs MHC class II antigen presentation capacity of macrophages

open access: yes, 2000
During African trypanosomiasis, macrophages play a central role in T cell hyporesponsiveness to parasite-related and unrelated antigens. In this study, the ability of macrophages from Trypanosoma b. brucei-infected mice to present exogenous antigens to a
Beschin, A   +4 more
core   +2 more sources

Determination of a predictive cleavage motif for eluted major histocompatibility complex class II ligands [PDF]

open access: yes, 2018
CD4+ T cells have a major role in regulating immune responses. They are activated by recognition of peptides mostly generated from exogenous antigens through the major histocompatibility complex (MHC) class II pathway.
Dhanda, Sandeep Kumar   +7 more
core   +6 more sources

MHC Class II Deficiency

open access: yesMedicine, 2001
IntroductionPrimary human immunodeficiencies constitute a heterogenous group of inborn errors of the immune system due to a variety of genetic abnormalities. The study of patients with primary immunodeficiency diseases has expanded our understanding of immunity.
J, Villard   +4 more
openaire   +2 more sources

Expression of MHC II genes

open access: yes, 2005
Innate and adaptive immunity are connected via antigen processing and presentation (APP), which results in the presentation of antigenic peptides to T cells in the complex with the major histocompatibility (MHC) determinants.
Drozina, G.   +3 more
core   +2 more sources

The cytoplasmic domain of CD4 promotes the development of CD4 lineage T cells. [PDF]

open access: yes, 1996
Thymocytes must bind major histocompatibility complex (MHC) proteins on thymic epithelial cells in order to mature into either CD8+ cytotoxic T cells or CD4+ helper T cells.
Corbella, P   +5 more
core  

Model for the Interaction of T-cell Receptors with Peptide/MHC Complexes [PDF]

open access: yes, 1989
The immune response against a viral infection is mediated by two different types of cells known as B and T lymphocytes. The receptor on the B cell is the well-characterized antibody molecule, which exists in a membrane-bound form and in a secreted form ...
Bjorkman, P. J., Davis, M. M.
core   +1 more source

Boosting immune response with the invariant chain segments via association with non-peptide binding region of major histocompatibility complex class II molecules

open access: yesBMC Immunology, 2012
Background Based on binding of invariant chain (Ii) to major histocompatibility complex (MHC) class II molecules to form complexes, Ii-segment hybrids, Ii-key structure linking an epitope, or Ii class II-associated invariant chain peptide (CLIP) replaced
Chen Fangfang   +5 more
doaj   +1 more source

In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients: Implications for the establishment and maintenance of donor cell chimerism following liver transplantation [PDF]

open access: yes, 1995
Dendritic cell (DC) progenitors were propagated in liquid culture from nonparenchymal cells resident in normal mouse (B10.BR; H-2k, I-E+) liver in response to granulocyte-macrophage colony stimulating factor (GM-CSF).
Fung, JJ   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy